""Ying Huang"" — Epstein Files Search

Search Entities About Settings

/to search

Dataset

Sort

Status

DOJ Status

Date Range

–

Page Count

–

3 results for “"Ying Huang"”

EFTA01088033Set 9

Keyboard Shortcuts

/

Focus search

Esc

Blur input

O

Open PDF

←→

Paginate

2016-04-1921p9,988w

quicker development of the triple combo for heterozygous F508del patients. Analyst Certification I, Ying Huang, hereby certify that the views expressed in this research report accurately reflect my personal views ... Huang Cni-med HCM HCM US Yrig Huang Cytomx Thempeulics Inc. CTMX CTAIX US Ying Huang DEIV Tectinobgies DBVT DBVT US Taasen Ahmad Escerion ESPR ESPR US Colin Bristow ... Taasen Ahmad Neron Therapeutics HRTX HRTX US Tazeen Ahmad Incyte Corporation INCY INCY US Ying Huang Ircowcal Ftarmaceuticals IRWD iRWO US Viro Huang Medivation MDVN MDVN US laman Ahmad Pacira

https://www.justice.gov/epstein/files/DataSet%209/EFTA01088033.pdf

EFTA02454617Set 11

2016-08-082p296w

interested and I'll try to get a slot. BofAML biotech analyst Ying Huang is hosting a Physician Dinner with Dr. Yaacov Anziska, M.D, M.S. Assistant Professor in the department ... nusinersen and the market opportunity for treatment of SMA infants and children. Host: Ying Huang Sector Specialist: Dan Lundquist Corporate Access: Caroline Goodson Time/Location: 7PM/Midtown location TBA Format: Group Dinner

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02454617.pdf

EFTA00822652Set 9

2016-08-034p1,098w

last Friday, the largest in 16 months - {NSN OBAVT36TTDSO <G0).}. BofA-ML biotech analyst Ying Huang note overnight: Biotechnology: Time to put your money to work. NBI underperformed S&P500

https://www.justice.gov/epstein/files/DataSet%209/EFTA00822652.pdf

Corpus: 1990-03-17 – 2025-12-01

April 2016

Mo

Tu

We

Th

Fr

Sa

Su

None

Light

Medium

Heavy

Results by Dataset3 total

Set 9

2

Set 11

1